Singular Genomics is based in San Diego, California. It has raised $384M in total funding. Latest round: IPO.
Singular Genomics funding overview
Singular Genomics is based in San Diego, California. Singular Genomics has raised $384M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2021. The round record for Singular Genomics runs through 2021; nothing later has been disclosed. Investors on record include Deerfield Management, JPMorgan Chase, Goldman Sachs, BofA Securities, Cowen, UBS. 6 distinct backers are named across the disclosed rounds.
Singular Genomics has raised $384M in total disclosed funding across the rounds on record.
Who has invested in Singular Genomics?
Deerfield Management, JPMorgan Chase, Goldman Sachs, BofA Securities, Cowen, UBS are named among the investors backing Singular Genomics.
What was the latest Singular Genomics funding round?
The most recent disclosed round is an IPO, announced in April 2021.
Where is Singular Genomics based?
Singular Genomics is based in San Diego, California.
When did Singular Genomics last raise?
The last disclosed Singular Genomics round closed in April 2021 at IPO.
Singular Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.
